GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Other Operating Expense

CSPC Pharmaceutical Group (HKSE:01093) Other Operating Expense : HK$2 Mil (TTM As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group Other Operating Expense?

CSPC Pharmaceutical Group's Other Operating Expense for the three months ended in Dec. 2023 was HK$0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$2 Mil.

CSPC Pharmaceutical Group's quarterly Other Operating Expense declined from Jun. 2023 (HK$41 Mil) to Sep. 2023 (HK$-58 Mil) but then increased from Sep. 2023 (HK$-58 Mil) to Dec. 2023 (HK$0 Mil).

CSPC Pharmaceutical Group's annual Other Operating Expense declined from Dec. 2021 (HK$0 Mil) to Dec. 2022 (HK$0 Mil) and declined from Dec. 2022 (HK$0 Mil) to Dec. 2023 (HK$-0 Mil).


CSPC Pharmaceutical Group Other Operating Expense Historical Data

The historical data trend for CSPC Pharmaceutical Group's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Other Operating Expense Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -167.16 -692.90 - - -

CSPC Pharmaceutical Group Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 18.96 41.03 -58.09 -

CSPC Pharmaceutical Group Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CSPC Pharmaceutical Group Other Operating Expense Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


CSPC Pharmaceutical Group (HKSE:01093) Business Description

Traded in Other Exchanges
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (HKSE:01093) Headlines

No Headlines